
Advances in DNA/RNA chromatography columns led to stable, pure mRNA production, supporting the development of COVID-19 vaccines rapidly.
This application note highlights a new multi-modal LC-MS/MS approach enabling robust analysis of polar and ionic metabolites without derivatization or ion-pairing.






